Is Novo Nordisk A/S (NVO) a Buy, Sell, or Hold?
NYSE : NVO
Novo Nordisk A/S — Analyst Ratings
$47.075 USD
-$4.54 (-8.79%)
- Volume
- 25.17M
- Average Volume
- 12.51M
- Market Capitalization
- $209.19B
- P/E Ratio
- 11.12
- Dividend Yield
- 3.83%
- Price Target
- $45.00
- Year High
- $64.16
- Year Low
- $35.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.42
- Current Ratio
- $0.79
Analyst Consensus Summary
Consensus Rating
Buy
39 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
4.6%
vs Current Price
Price Target
$45.00
Average TargetPrice Target Range
Lowest Target
$45.00
4.6% UPSIDE
Average Target
$45.00
Median Estimate
Highest Target
$45.00
4.6% UPSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 39
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 22 | 13 | 3 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| BMO Capital | Evan Seigerman | $57 | $63.8 | 2026-01-26 09:36 AM | -10.7% |
| Morgan Stanley | Thibault Boutherin | $42 | $47.43 | 2025-12-03 06:31 AM | -11.4% |
| BMO Capital | Evan Seigerman | $46 | $44.97 | 2025-11-25 04:26 AM | 2.3% |
| BMO Capital | Evan Seigerman | $55 | $57.5 | 2025-10-14 07:29 AM | -4.3% |
| Truist Financial | Jailendra Singh | $48 | $70.03 | 2025-07-23 04:08 PM | -31.5% |